A Message from Eric Genden, MD
Eric M. Genden, MD, FACS, Professor and Chair Otolaryngology-Head and Neck Surgery, reflects on the Department’s exciting year that can be characterized as an exploration into uncharted research and technology.
A fierce foray into uncharted research and technology can describe how vibrant the year 2021 was for the Department of Otolaryngology-Head and Neck Surgery at the Icahn School of Medicine at Mount Sinai. You, as an otolaryngologist, might have been similarly inspired to forge into unknown territory on the heels of continuous adaptation and managing COVID-19 in your practice.
In operation for more than a century, the Department of Otolaryngology-Head and Neck Surgery at the Icahn School of Medicine at Mount Sinai has earned a reputation as one of the finest in the nation and is internationally recognized for its groundbreaking clinical advances in the field.
The Department’s physicians have gained national recognition for their expertise and innovation in reconstructive surgery and the diagnosis and treatment of diseases of the ears, nose, and throat, as well as tumors of the head, neck, and skull base. Mount Sinai Health System hospitals were among the first in the United States to use minimally invasive TransOral Robotic Surgery (TORS) for oral and throat malignancies and among the first to establish a Head and Neck Institute. And, in 2021, a team of surgeons led by Eric M. Genden, MD, MHCA, FACS, performed the first human trachea transplant.